HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decrease of sexual receptivity by prolylendopeptidase inhibitor in female rats.

Abstract
The effects of a prolylendopeptidase inhibitor, 1-[3-(2-indanylanylacetyl)-L-thioprolyl]pyrrolidine (Z-321), on lordosis behavior were investigated in estrogen and progesterone-treated ovariectomized rats. Females were orally administered 100, 200 or 300 mg/kg Z-321 or the vehicle (control). The mean lordosis quotient in the rats given 300 mg/kg Z-321 was lower than that in control group, but that in rats given 100 or 200 mg/kg Z-321 was not lower. Thus, Z-321 suppressed lordosis in estrogen and progesterone-treated ovariectomized rats. Peptide neurotransmitters, especially those containing proline, are thought to be involved in the inhibitory mechanisms for lordosis behavior.
AuthorsI Oosuka, Y Tanaka, N Miura, K Yamanouchi
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 83 Issue 1 Pg. 82-5 (May 2000) ISSN: 0021-5198 [Print] Japan
PMID10887944 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 1-(3-(2-indanylacetyl)-L-thioprolyl)pyrrolidine
  • Protease Inhibitors
  • Pyrrolidines
  • Vasopressins
  • Cholecystokinin
  • Serine Endopeptidases
  • PREPL protein, human
  • Prolyl Oligopeptidases
Topics
  • Animals
  • Cholecystokinin (physiology)
  • Female
  • Motor Activity (drug effects)
  • Posture
  • Prolyl Oligopeptidases
  • Protease Inhibitors (pharmacology)
  • Pyrrolidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Serine Endopeptidases (physiology)
  • Sexual Behavior, Animal (drug effects)
  • Vasopressins (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: